BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 29, 2006
View Archived Issues
BPC-157 evaluated in model of anastomosis healing
Read More
DDP-733 increases lower esophageal sphincter pressure in cats
Read More
Cardiome updates progress of RSD-1235 through quarter
Read More
Medarex offers overview of inhouse and partnered programs
Read More
URB-597 has antidepressant activity in animal models
Read More
Cannabinoid receptor 2 a target for osteoporosis
Read More
In vitro studies show osteoporosis treatment potential of kobophenol A
Read More
Pagoclone produces decrease in severity of stuttering
Read More
7TM Pharma acquires CareX
Read More
Clinical results support further development of BAY 79-4980 for hemophilia A
Read More
EnVivo sets out plans for drug development progression
Read More
Proof-of-concept study for NicVAX in smoking cessation
Read More
AST-120 studied in North America and Europe for fistulizing Crohn's disease
Read More
VQD-002 studied in new phase I/IIa trial for solid tumors
Read More
Preclinical safety studies completed for oral calcitonin program
Read More
Enrollment completed in MERLIN TIMI-36 study of ranolazine
Read More
Second U.S. phase III study of Zadaxin in HCV fails to meet primary endpoint
Read More
Eraxis launched in U.S. for antifungal indications
Read More
Novel therapeutic agents for respiratory disorders disclosed in recent patent literature
Read More
Recent patents describe novel agents for anxiety, depression, psychosis, etc.
Read More
New treatment options for inflammatory disorders disclosed
Read More
Ganfort approved for glaucoma in E.U.
Read More
Iplex now available for primary IGFD
Read More
Avastin filed for first-line treatment of metastatic breast cancer
Read More
Accelerated approval for Thalomid in multiple myeloma
Read More
Seasonique extended-cycle oral contraceptive receives FDA approval
Read More
Cubicin approved for S. aureus bloodstream infections
Read More
Zostavax approved in U.S. for prevention of shingles
Read More
Cannabinoid CB2 receptors as a target for anxiety and substance abuse
Read More